IRIS Accounts Production v24.3.2.46 09069003 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090690032023-06-30090690032024-06-30090690032023-07-012024-06-30090690032022-06-30090690032022-07-012023-06-30090690032023-06-3009069003ns15:EnglandWales2023-07-012024-06-3009069003ns14:PoundSterling2023-07-012024-06-3009069003ns10:Director12023-07-012024-06-3009069003ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3009069003ns10:SmallEntities2023-07-012024-06-3009069003ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3009069003ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3009069003ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3009069003ns10:FullAccounts2023-07-012024-06-3009069003ns10:OrdinaryShareClass12023-07-012024-06-3009069003ns10:OrdinaryShareClass22023-07-012024-06-3009069003ns10:OrdinaryShareClass32023-07-012024-06-3009069003ns10:Director22023-07-012024-06-3009069003ns10:RegisteredOffice2023-07-012024-06-3009069003ns5:CurrentFinancialInstruments2024-06-3009069003ns5:CurrentFinancialInstruments2023-06-3009069003ns5:Non-currentFinancialInstruments2024-06-3009069003ns5:Non-currentFinancialInstruments2023-06-3009069003ns5:ShareCapital2024-06-3009069003ns5:ShareCapital2023-06-3009069003ns5:RetainedEarningsAccumulatedLosses2024-06-3009069003ns5:RetainedEarningsAccumulatedLosses2023-06-3009069003ns5:PlantMachinery2023-06-3009069003ns5:FurnitureFittings2023-06-3009069003ns5:ComputerEquipment2023-06-3009069003ns5:PlantMachinery2023-07-012024-06-3009069003ns5:FurnitureFittings2023-07-012024-06-3009069003ns5:ComputerEquipment2023-07-012024-06-3009069003ns5:PlantMachinery2024-06-3009069003ns5:FurnitureFittings2024-06-3009069003ns5:ComputerEquipment2024-06-3009069003ns5:PlantMachinery2023-06-3009069003ns5:FurnitureFittings2023-06-3009069003ns5:ComputerEquipment2023-06-3009069003ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3009069003ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3009069003ns10:OrdinaryShareClass12024-06-3009069003ns10:OrdinaryShareClass22024-06-3009069003ns10:OrdinaryShareClass32024-06-30
REGISTERED NUMBER: 09069003 (England and Wales)















Unaudited Financial Statements

for the Year Ended 30 June 2024

for

LANCS MEDICAL LTD

LANCS MEDICAL LTD (REGISTERED NUMBER: 09069003)

Contents of the Financial Statements
for the year ended 30 June 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LANCS MEDICAL LTD

Company Information
for the year ended 30 June 2024







Directors: K Roberts
D G Roberts





Registered office: Paddock House
Links Lane
Pleasington
Blackburn
BB2 5JL





Registered number: 09069003 (England and Wales)





Accountants: Evelyn Partners (Manchester) Limited
Accountants
Northern Assurance Buildings
9-21 Princess Street
Manchester
M2 4DN

LANCS MEDICAL LTD (REGISTERED NUMBER: 09069003)

Balance Sheet
30 June 2024

2024 2023
Notes £ £ £ £
Fixed assets
Tangible assets 5 4,983 5,938

Current assets
Debtors 6 115,244 70,798
Cash at bank 210,810 135,559
326,054 206,357
Creditors
Amounts falling due within one year 7 107,117 59,356
Net current assets 218,937 147,001
Total assets less current liabilities 223,920 152,939

Creditors
Amounts falling due after more than one
year

8

28,539

32,960
Net assets 195,381 119,979

Capital and reserves
Called up share capital 9 110 110
Retained earnings 195,271 119,869
Shareholders' funds 195,381 119,979

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 December 2024 and were signed on its behalf by:




D G Roberts - Director


LANCS MEDICAL LTD (REGISTERED NUMBER: 09069003)

Notes to the Financial Statements
for the year ended 30 June 2024


1. Statutory information

Lancs Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. Employees and directors

The average number of employees during the year was 13 (2023 - 11 ) .

LANCS MEDICAL LTD (REGISTERED NUMBER: 09069003)

Notes to the Financial Statements - continued
for the year ended 30 June 2024


5. Tangible fixed assets
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£ £ £ £
Cost
At 1 July 2023 7,318 2,489 4,629 14,436
Additions - - 1,590 1,590
At 30 June 2024 7,318 2,489 6,219 16,026
Depreciation
At 1 July 2023 4,320 1,348 2,830 8,498
Charge for year 750 622 1,173 2,545
At 30 June 2024 5,070 1,970 4,003 11,043
Net book value
At 30 June 2024 2,248 519 2,216 4,983
At 30 June 2023 2,998 1,141 1,799 5,938

6. Debtors: amounts falling due within one year
2024 2023
£ £
Trade debtors 81,807 31,420
Other debtors 33,437 39,378
115,244 70,798

7. Creditors: amounts falling due within one year
2024 2023
£ £
Bank loans and overdrafts 5,556 5,556
Trade creditors 12,482 26,465
Taxation and social security 58,849 21,843
Other creditors 30,230 5,492
107,117 59,356

8. Creditors: amounts falling due after more than one year
2024 2023
£ £
Bank loans 28,539 32,960

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 6,317 10,738

LANCS MEDICAL LTD (REGISTERED NUMBER: 09069003)

Notes to the Financial Statements - continued
for the year ended 30 June 2024


9. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
50 A Ordinary 1 50 50
50 B Ordinary 1 50 50
10 C Ordinary 1 10 10
110 110

10. Directors' advances, credits and guarantees

The following advances and credits to directors subsisted during the years ended 30 June 2024 and 30 June 2023:
20242023
£   £   
Balance outstanding at the start of year24,8626,875
Amounts advanced13,52624,862
Amounts repaid(15,568)(6,874)
Balance outstanding at the end of the year22,82124,862

The above loans are interest free and repayable on demand.